Document Detail


Cytomegalovirus infection in a patient with atypical Kawasaki disease.
MedLine Citation:
PMID:  17717671     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Kawasaki disease (KD) is an acute, febrile, and multisystem vasculitis of early childhood with a striking predilection for the coronary arteries. The most significant complication is coronary artery abnormalities, including coronary aneurysms. The etiology of KD remains unknown. Many infectious agents including viruses have been postulated as possible causes of KD. But standard microbiologic techniques, molecular methods and serologic investigations have failed to identify an etiologic agent. We described a patient with atypical KD during cytomegalovirus infection.
Authors:
Belgin Usta Guc; Nurcan Cengiz; Selman Vefa Yildirim; Yasemin Uslu
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2007-08-24
Journal Detail:
Title:  Rheumatology international     Volume:  28     ISSN:  0172-8172     ISO Abbreviation:  Rheumatol. Int.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-01-09     Completed Date:  2008-07-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8206885     Medline TA:  Rheumatol Int     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  387-9     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Faculty of Medicine, Adana Teaching and Medical Research Center, Baskent University, Adana, Turkey. defneusta@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Antibodies, Viral / blood
Aspirin / therapeutic use
Ceftriaxone / therapeutic use
Cytomegalovirus / genetics,  immunology
Cytomegalovirus Infections / complications*,  diagnosis,  drug therapy,  ultrasonography
DNA, Viral / blood
Female
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunologic Factors / therapeutic use
Infant
Mucocutaneous Lymph Node Syndrome / drug therapy,  ultrasonography,  virology*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Antibodies, Viral; 0/DNA, Viral; 0/Immunoglobulins, Intravenous; 0/Immunologic Factors; 50-78-2/Aspirin; 73384-59-5/Ceftriaxone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Frequency of HLA-B27 and its alleles in patients with Reiter syndrome: comparison with the frequency...
Next Document:  Increased senescence-associated gene expression and lipid peroxidation induced by iron deficiency in...